학술논문
Sacituzumab Govitecan for the treatment of advanced triple negative breast cancer patients: a multi-center real-world analysis
Document Type
article
Author
Source
Frontiers in Oncology, Vol 14 (2024)
Subject
Language
English
ISSN
2234-943X
Abstract
ObjectiveThe objective of this multicenter, observational, retrospective analysis was to evaluate the safety and efficacy of sacituzumab govitecan in metastatic triple-negative breast cancer (mTNBC) patients managed according to common clinical practice in Italy.MethodsData were retrieved by 7 sites. Triple-negative BC was defined by the lack of expression of estrogen receptor (ER